MedPath

Nutraceutical Supplement in the Management of Hypertension

Phase 1
Completed
Conditions
Hypertension
Interventions
Dietary Supplement: Cardiopressin
Dietary Supplement: Placebo
Registration Number
NCT02663479
Lead Sponsor
Thorne HealthTech, Inc
Brief Summary

The purpose of this study is to evaluate the efficacy and safety of a proprietary nutraceutical supplement in capsule form over 4 months in treating blood pressure in a group of chronic hypertensive subjects that are not receiving any pharmaceutical anti-hypertensive agents or other nutraceutical supplements.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CardiopressinCardiopressinA 5 capsule proprietary blend of herbal extracts and nutrients
PlaceboPlaceboA 5 capsule placebo matched in color and size to the Experimental supplement
Primary Outcome Measures
NameTimeMethod
Blood Pressure4 months

Reduction in systolic and diastolic blood pressure as measured by office readings and 24 hour ABM ( ambulatory blood pressure monitor)

Secondary Outcome Measures
NameTimeMethod
Endothelial Function4 months

Measured via Endopat

Small arterial compliance4 months

Measured via computerized arterial pulse wave analysis (CAPWA)

Large arterial compliance4 months

Measured via computerized arterial pulse wave analysis (CAPWA)

Central arterial blood pressure4 months

Measured via computerized arterial pulse wave analysis (CAPWA)

Trial Locations

Locations (1)

Hypertension Institute of Nashville, TN

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath